Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up

Overview of attention for article published in Frontiers in immunology, February 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 467 followers.

New article: Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up https://t.co/HyXRgv62Qj #MS #multiplesclerosis #neurology https://t.co/jVWGNqWVWO

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.